readthroughSign in
CompanyARGXNasdaqZwijnaarde

argenx

argenx develops antibody-based medicines for severe autoimmune diseases.

10-QNov 13Latest SEC filing
Nov 9Latest story

November 2026

October 2026

September 2026

August 2026

July 2026

June 2026